CATAPHARMA

About us

The Catapharma Group was formed in 1986 with the coming together of three young chemical engineers with a strong desire to apply their technical skills to productive industrial activity. Dr. Shrikant Karwa, the founder of the Group, has, to his credit, a doctoral thesis on Principles of Liquid-phase Catalytic Hydrogenation and a few international publications and review articles in the same field. With no industrial experience and only his university research as his asset, he directly ventured to transform his technological insight into industrial reality. Presently, the group comprises of 110 people with annual turn over of $ 7 millions. The core activity is manufacture of pharmaceutical intermediates and fine chemicals. This is backed up by well equipped research lab and pilot plant for development of new products and up-gradation of existing processes. Technological Expertise The Group concentrated its efforts to master the technology of liquid-phase hydrogenation, which included critical equipment design, and preparation of active and selective catalysts. As on date, the Group has mastered catalyst design and equipment design for reduction of various functional groups. The insight has resulted into three self-sufficient manufacturing sites; erected and commissioned by a…  Click for details>>